These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17541325)

  • 1. ACE inhibitors and ARBs: are they better than other agents to slow nephropathy progression?
    Bakris GL
    J Clin Hypertens (Greenwich); 2007 Jun; 9(6):413-5. PubMed ID: 17541325
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contribution of diuretics to the treatment of hypertension in patients with CKD].
    Ura N; Yamaji I
    Nihon Jinzo Gakkai Shi; 2009; 51(4):446-50. PubMed ID: 19601551
    [No Abstract]   [Full Text] [Related]  

  • 3. Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
    Jain AK; Cuerden MS; McLeod I; Hemmelgarn B; Akbari A; Tonelli M; Quinn RR; Oliver MJ; Garg AX
    Kidney Int; 2012 Jun; 81(12):1248-53. PubMed ID: 22437415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of calcium channel blocker in hypertensive patients with chronic kidney disease].
    Morihira M; Kikuchi K; Nakagawa N; Fujino T; Hasebe N
    Nihon Jinzo Gakkai Shi; 2009; 51(4):451-5. PubMed ID: 19601552
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?
    Messerli FH; Bangalore S; Bavishi C; Rimoldi SF
    J Am Coll Cardiol; 2018 Apr; 71(13):1474-1482. PubMed ID: 29598869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The renin-angiotensin system in hypertension and in cardiovascular and renal diseases: highlights of the World Congress of Nephrology 2009]].
    Romet M
    Nephrol Ther; 2010 Jan; 6 Spec No 1():H10-3. PubMed ID: 20129455
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Hypertension Management: treatment of hypertension in patients with type 2 diabetes mellitus.
    Nilsson PM; Cifkova R; Kjeldsen SE
    J Hypertens; 2006 Jan; 24(1):208-10. PubMed ID: 16331123
    [No Abstract]   [Full Text] [Related]  

  • 10. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
    Griffin KA; Bidani AK
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence?
    Mallat SG
    Cardiovasc Diabetol; 2013 Jul; 12():108. PubMed ID: 23866091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.
    Casas JP; Chua W; Loukogeorgakis S; Vallance P; Smeeth L; Hingorani AD; MacAllister RJ
    Lancet; 2005 Dec; 366(9502):2026-33. PubMed ID: 16338452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin inhibitors in stage 4 chronic kidney disease.
    Hirsch S
    Kidney Int; 2006 Nov; 70(10):1880; author reply 1880-1. PubMed ID: 17080165
    [No Abstract]   [Full Text] [Related]  

  • 14. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M; Franchini M; Fanos V
    Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V; Buksa M; Loza V; Kulic M
    Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease.
    Omae K; Ogawa T; Nitta K
    Heart Vessels; 2010 May; 25(3):203-8. PubMed ID: 20512447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Remission Clinic approach to halt the progression of kidney disease.
    ;
    J Nephrol; 2011; 24(3):274-81. PubMed ID: 21534237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The renin-angiotensin-aldosterone system -- more complex as previously thought].
    Wolf G
    Med Klin (Munich); 2005 Aug; 100(8):471-7. PubMed ID: 16096728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing renal disease progression: is it the drug or the blood pressure reduction, or both?
    Weir MR
    Curr Hypertens Rep; 2000 Dec; 2(6):497-9. PubMed ID: 11062593
    [No Abstract]   [Full Text] [Related]  

  • 20. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G
    Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.